These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Effectiveness of the repeated administration of scopolamine ointment on clozapine-induced hypersalivation in patients with treatment-resistant schizophrenia: A preliminary study.
    Author: Takeuchi I, Hanya M, Uno J, Fujita K, Kamei H.
    Journal: Asia Pac Psychiatry; 2017 Dec; 9(4):. PubMed ID: 29193710.
    Abstract:
    INTRODUCTION: This study investigated the efficacy of scopolamine (an anticholinergic agent) ointment against clozapine-induced hypersalivation. METHODS: The patients enrolled in this study consisted of 10 clozapine-treated schizophrenia patients and 10 healthy adult men. A prospective, randomized, double-blind, crossover, placebo-controlled clinical trial was designed. RESULTS: A total of 10 patients and 10 healthy adult men completed the study. No significant reduction in the saliva production of the clozapine-treated patients was observed; however, that of the healthy adult men decreased significantly. DISCUSSION: Scopolamine ointment was not effective against clozapine-induced hypersalivation. A further study is necessary for confirming its effect.
    [Abstract] [Full Text] [Related] [New Search]